TINU syndrome was first described in 1975 by Dobrin . This syndrome is characterized by the association of acute tubulointerstitial involvement and uveitis, most often anterior and bilateral, apart from any systemic disease likely to cause this symptomatology . Its incidence would be underestimated, only 200 cases have been reported during the last forty years . The pathophysiology is still poorly understood; it may be an autoimmune disorder secondary to environmental, drug or infectious triggering factors . The prognosis in the majority of cases is favorable . There is no standardized treatment, but the majority of cases have been treated with corticosteroid therapy and/or immunosuppressant .
2. Material and Method
We have identified two clinical cases of tinu syndrome in the pediatric rheumatology department at the children’s hospital at the Ibn Rochd Casablanca University Hospital.
CLINICAL CASE N˚1:
Young girl, 15 years old, with no particular pathological history. Accepted for the aetiological assessment of bilateral anterior uveitis developing in a context of deterioration of the general condition with weight loss estimated at 12 kg over the space of 2 months. Interrogation did not reveal any recent infectious episode, nor medication, oral aphthosis or arthralgia. The clinical examination noted the presence on the urine dipstick of 2 protein crosses. The para-clinical examination revealed an inflammatory syndrome with a sedimentation rate of 110 mm, a normochromium normocytic anemia at 9.6 g/dl of hemoglobin, severe acute renal failure at 56 mg/l, i.e. a glomerular filtration rate. At 15 ml/min/1.73 m2 with a preserved diuresis, proteinuria for 24 h at 1 g/24 h, cytobacteriological examination of the urine does not reveal leukocyturia, hematuria or glycosuria. The abdominopelvic ultrasound was unremarkable. An etiological assessment looking for tuberculosis, toxoplasmosis, sarcoidosis, acute systemic lupus erythematosus, Sjogren, behçet was negative. A renal puncture biopsy for diagnostic, therapeutic and etiological purposes was performed in the aftermaths were simple. Renal biopsy revealed an inflammatory mononuclear infiltrate made up of interstitial lymphoplasmacytic cells without vascular or glomerular lesions. Immunofluorescence negative. The patient received 3 boluses of methyl prednisolone followed by oral corticosteroid therapy. The evolution was marked by improvement in the clinical and biological state with normalization of renal function, negativation of 24-hour proteinuria and regression of uveitis after 5 weeks.
CLINICAL CASE N 2:
16-year-old girl, with no particular pathological history. Hospitalized for the aetiological assessment of a bilateral anterior uveitis progressing for 4 weeks in a context of apyrexia and maintenance of general condition. The examination did not reveal any recent infectious episode or drug intake, oral aphthosis or arthralgia. The clinical examination was unremarkable. The urine dipstick notes the presence of normoglycemic glycosuria. On the biological assessment, an inflammatory syndrome with an accelerated sedimentation rate, a negative C reactive protein, a normochromic normocytic anemia at 8.8 g/dl of hemoglobin. Acute renal failure with sustained diuresis with plasma creatinine at 16.8 mg/l, i.e. a glomerular filtration rate of 43 ml/min/1.73 m2. On cytobacteriological examination, amicrobial leukocyturia is noted, with normoglycemic glycosuria. The 24-hour proteinuria is 1.2 g/24 h. The kidney ultrasound was normal. The etiologic infectious (tuberculosis, toxoplasmosis) and autoimmune assessment for sarcoidosis, systemic lupus erythematosus, Sjogren was negative. At the renal puncture biopsy we find an interstitial lymphoplasmacytic infiltrate with interstitial fibrosis, without glomerular lesion, nor vascular without granuloma, the immunofluorescence was negative. The patient received oral corticosteroid therapy at a dose of 1 mg/kg/day with a good clinical-biological evolution: regression of uveitis and improvement of renal function with normalization of renal function after 6 weeks with negativation of the 24 h proteinuria (Table 1)
These are two female patients. Average age at diagnosis was 16 years. The inaugural symptoms were bilateral anterior uveitis in both cases. The time to discovery of renal signs compared to uveitis: is 4 weeks to 2 months. Acute renal failure
Table 1. Sociodemographics and clinical charactersitics and the participants.
with retained urine output was reported in both cases with a mean creatinine of 36.4 mg/l. A mean proteinuria of 1.1 g/24 h associated with aseptic leukocyturia in 1 case/2 and normoglycemic glycosuria in 1 case/2. A non-specific inflammatory syndrome with inflammatory anemia is found in both cases. At the renal puncture-biopsy, we find an inflammatory interstitial infiltrate mononuclear lymphoplasmacytic without granuloma, with interstitial fibrosis in 1/2 cases. The immunofluorescence was negative in both cases. Oral corticosteroid therapy (1 mg/kg per day) was started for 3 to 6 months in both patients. Local treatment with corticosteroids for uveitis was given in both patients. The outcome was favorable under treatment with complete recovery of renal function between 4 - 6 weeks and remission of uveitis.
1) Prevalence and incidence:
The first case of TINU syndrome was described in 19751 in two adolescent girls. Since 200 cases have been reported over the last forty years, worldwide  , in pediatric and ophthalmological journals as clinical cases or series of cases. The incidence and prevalence of TINU syndrome are reportedly underestimated. It is believed to be the cause of less than 2% of uveitis cases in ophthalmology units   and less than 15% of cases of acute tubulo-intestinal nephritis in nephropediatric departments .
2) Demographic factors:
The TINU syndrome is more described in the pediatric population: In an important review of the literature, concerning 133 cases, Mandeville found a median age of 15 years (9 years - 74 years) 2. These results are similar to the study by Mackensen reporting a median age of 15 years (6 years - 64 years)  and to a Japanese study conducted by Goda . However, other cases have been reported at older ages .
According to Mandeville et al., there is a female predominance at 74% (98/133) confirmed by the Mackensen study at 60%. But the percentage of male patients increased (from 18% before 1990 to 34% after 1990) . It has been suggested that gender might affect age: according to Mandeville the median age is 14 years for males versus 17 years for females , also for Mackensen with a median age of 15 for male versus 40 years old for females .
Ethnic predisposition 2 has not been described.
The pathophysiology of TINU syndrome remains incompletely understood.
All of the elements reported in the medical literature revive the hypothesis of an autoimmune cell and humoral mediated disease following a triggering factor in a patient with a predisposing genetic background.
1) Triggering factors:
Drug intake is most often found as a triggering factor, particularly after taking non-steroidal anti-inflammatory drugs or antibiotics .
Occasional associations have been described with: infectious pathologies such as Epstein Barr virus , chlamydiae  And autoimmune diseases such as primary hyperparathyroidism, hyperthyroidism, or rheumatoid arthritis.
2) Genetic predisposition:
Several studies have reported a genetic predisposition to tinu syndrom.
Levinson et al. noted the association of TINU syndrome with the HLA-DQA1 * 01, DQB1 * 05 alleles and particularly strongly with the HL-DRB1 * 0102 allele in 72% of cases 15. A case of a monozygous twin developed TINU syndrome at two-year intervals, confirming the role of genetics in this syndrome  .
3) Physio pathogenesis:
The pathophysiology of TINU syndrome remains unknown. Several cases described have hypothesized that it is a cellular and humoral autoimmune process . At Humoral-mediated immunity in TINU syndrome: There is a little evidence in the literature that points to the presence of a humoral mediated reaction. Polyclonal hypergammaglobulinemia and a non-specific biological inflammatory syndrome are found in the majority of cases of TINU syndrome  . In 1985, evidence of circulating immune complexes in a patient . In 2001, CONZ et al. noted the decrease in the level of complement C4 in the blood in a 48-year-old patient who presented with TINU syndrome . Wakaki et al. isolated serum IgG immunoglobulins directed against a kidney protein in a 13-year-old girl with TINU syndrome . Abed et al., in a 15-year-old patient, demonstrated the presence of IgG autoantibodies directed towards antigens common to renal tubular cells and uveal cells present in the ciliary bodies and the iris . In 2011, in a Chinese study in Beijing, autoantibodies directed against the mCRP protein (modified C Reactive Protein) present without tubular cells and uveal cells have been found in the blood of patients with TINU syndrome . The case of recurrence of TINU syndrome in a patient after renal transplantation  The pathogenic role of anti-tubular basement membrane antibodies in the kidney and in the serum remains to be demonstrated. b. Cell mediated immunity: Cellular immunity is central in the pathophysiology of TINU syndrome . Demonstrated during renal biopsies by the presence of an interstitial infiltrate made up of monocytes and lymphocytes and seen in association with specific HLA genotypes. In uveitis and interstitial nephritis, there is an inflammatory immunological process following the interaction of antigen, T lymphocyte and cytokines: • The suspect antigen binds to the Toll-like receptor present on the surface of the antigen presenting cell (APC) • Triggering of the innate immune response, release of cytokines and pro-inflammatory proteins responsible for tissue damage which leads to exposure and modification of antigen sites with escape from the mechanism of tolerance and induction of an auto-immune response against auto-antigens. • Triggering of an acquired immune response by the activation of T lymphocytes by the antigen-HLA complex (major histocompatibility complex), differentiation of T lymphocytes, formation of cytotoxic T lymphocytes, release of cytotoxins, recruitment of B lymphocytes, activation and differentiation in plasma cells and autoantibody release with tissue damage (Figure 1).
Figure 1. Diagram illustrating the pathogenesis of tubulo nephritis interstitial and uveitis in tinu syndrome . (1) Triggering antigen binds to its receptor Toll-like ligand on the surface of the antigen presenting cell. (2) Activation of signaling. (3) 2 processes result: (a) innate immunity in red, (b) acquired immunity in blue (4) innate immunity: the antigen presenting cells encode pro-inflammatory proteins and cytokines inducing lesions tissue and self-antigen formation (5) acquired immunity: T lymphocyte receptors recognize the Ag HLA complex, activation of T lymphocytes: recruitment of B lymphocytes, production of cytokines, direct cyto toxicity of T lymphocytes. (6) Antibody production. (7) Humoral and cellular response of the acquired immune response. (8) Antibody directed against the triggering antigen. (9) Tissue damage which leads to exposure and modification of the sites antigens with escape from the mechanism of tolerance and induction of an autoimmune response against autoantigens
4.3. Circumstance of Discovery
1) General Events:
Alteration of the general condition with asthenia, weight loss, arthralgia, fever. b. Renal manifestations: Renal involvement is most often initial in 65% following a flu-like syndrome. vs. Ocular manifestations: • Red eye, red, blurred vision, photophobia. • “Ocular involvement may be initial in 20%. May appear at the time of diagnosis of renal failure Delayed a few months or even a year after diagnosis of renal failure.
Renal and extrarenal manifestations are summarized Table 2.
● Renal impairment:
Acute or subacute renal failure, of varying severity, is found in 2/3 of patients with a serum creatinine level of 184 μmol/l at the time of diagnosis.
Signs typical of tubulointestinal renal impairment, an active urine sediment we can find an active urinary sediment: leukocyturia, hematuria, tubular proteinuria. ➢ A proximal tubular dysfunction such as normoglycemic glycosuria is frequent    , as was found in case N 2 or type of fanconi    .
➢ Distal tubular dysfunction, type polyuria  or distal tubular acidosis type 1 have also been reported. An increase in urinary excretion of markers of tubular renal damage to the type of beta 2 microglobulin, N-acetyl glucosaminidase (NAG) could be a diagnostic marker according to Goda and his collaborators who noted the increase in urinary excretion in 11 patients/12.
Another KL-6 marker, human glycoprotein, whose serum concentration is high in respiratory pathologies, used in monitoring the activity of sarcoidosis, was found to be significantly elevated in the blood of patients with TINU syndrome, by Kase and his collaborators .
● Ocular involvement:
In the TINU syndrome: “Uveitis is most often bilateral and anterior2, but can be intermediate   or posterior . All compartments of the uvea can be affected: choroid with chorioretinitis , choroidal neovascularization , optic nerve edema , macular edema  , sclerochoroiditis  c. Extrarenal and extra ocular involvement: Since it is an autoimmune phenomenon, inflammation can affect other organs: ➢ Thyroid: Hashimoto thyroiditis or Hyperthyroidism    Ear: Hearing loss and vestibular damage   ➢ Lungs: Alveolar pulmonary involvement  Joints: Arthritis  Localized or diffuse lymphadenopathy .
3) Renal histology:
Renal Biopsy Puncture makes it possible to make a positive diagnosis of renal involvement in TINU syndrome. Anatomopathological characteristics (Figure 2) ➢ Interstitial edema ➢ Marked interstitial inflammatory infiltrate - Peri-tubular - T lymphocytes - Monocytes-macrophages ➢ Eosinophils ➢ Granuloma ➢ Tubular abnormalities (necrosis) to varying degrees ➢ Fibrosis possible - Initially sparse at the cortico-medullary junction   .
Table 2. Renal and extrarenal manifestations of TINU. 1.
Figure 2. Renal biopsy of a young girl with TINU syndrome.
There is no standardized treatment for TINU syndrome.
1) Treatment of renal impairment:
Corticosteroids are the basic treatment.
Indicated in renal failure.
Oral corticosteroid therapy based on prednisone or prednisoslone.
Dose of 1 - 1.5 mg/kg/day  .
The duration and reduction of corticosteroid therapy depend on the type and speed of response of the patient.
Some cases have reported the use of immunosuppressants: Cyclophosphamide or mycophenolate mofetil  .
Other cases reported complete and spontaneous remission of renal involvement without treatment .
2) Treatment of uveitis:
Local corticosteroid therapy more or less oral corticosteroids.
In case of resistance to corticosteroids/use of immunosuppressants: Cyclophosphamide, Cyclosporine, Methotrexate, Mycophenolate Mofetil .
4.5. Evolution and Prognosis
1) Renal prognosis:
In general, tubulointertial nephritis progresses to spontaneous remission or under corticosteroid treatment. Some cases have reported recurrence of renal damage and persistence of end-stage chronic renal failure with the use of extrarenal cleaning. The renal prognosis depends on the severity of the tubulointertitial fibrosis
2) Ocular prognosis:
In general, there is a remission following treatment. However, relapses of uveitis are frequent and can be prevented by prolonged local treatment with corticosteroids or by immunosuppressive therapy based on methotrexate, cyclosporine A or azathioprine .
The incidence of TINU syndrome is on the rise, the epidemiology may change with greater involvement in the elderly and in males. It is an autoimmune disease promoted by triggers and genetic predisposition. There are diagnostic markers such as B2 microglobulin and KL-6 which may provide benefit in the future. You have to think about the different differential diagnoses before choosing the diagnosis of UTI. Collaboration between ophthalmologist, pediatric nephropologist and nephrologist is essential for a better.
 Dobrin, R.S., Vernier, R.L. and Fish, A.L. (1975) Acute Eosinophilic Interstitial Nephritis and Renal Failure with Bone Marrow Lymph Node Granulomas and Anterior Uveitis: A New Syndrome. The American Journal of Medicine, 59, 325-333.
 Mandeville, J.T.H., Levinson, R.D. and Holland, G.N. (2001) The Tubulointerstitial Nephritis and Uveitis Syndrome. Survey of Ophthalmology, 46, 195-208
 Hassane, I. (2008) Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): A Step Forward to Understanding an Elusive Oculorenal Syndrome. Nephrology Dialysis Transplantation, 23, 1095-1097.
 Deguchi, H.E. and Amemiya, T. (2003) Two Cases of Uveitis with Tubulointerstitial Nephritis in HTLV-1 Carriers. Japanese Journal of Ophthalmology, 47, 372-378.
 Mackensen, F, Smith, J.R. and Rosenbaum, J.T. (2007) Enhanced Recognition, Treatment, and Prognosis of Tubulointerstitial Nephritis and Uveitis Syndrome. Ophthalmology, 114, 995-999. E1.
 Kump, L.I., Cervantes-Castaneda, R.A., Androudi, S.N. and Foster, C.S. (2005) Analysis of Pediatric Uveitis Cases at a Tertiary Referral Center. Ophthalmology, 112, 1287-1292.
 Goda, C., Kotake, S., Ichiishi, A., Namba, K., Kitaichi, N. and Ohno, S. (2005) Clinical Features in Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome. American Journal of Ophthalmology, 140, 637-641.
 Lei, W.-H., Xin, J., Yu, X.-P., Li, J., Mao, M.-F., Ji, J.-S., et al. (2015) Tubulointerstitial Nephritis and Uveitis Syndrome in an Elderly Man. Case Report and a Review of the Literature. Medicine, 94, e2101.
 Santoro, D., Vita, G., Rovito, S., Venuto, L., Cavallari, V., Vita. R., et al. (2012) Drug-Induced TINU Syndrome and Genetic Characterization. Clinical Nephrology, 78, 230-236.
 Cigni, A., Soro, G., Faedda, R., Caucci, F., Amadori, F., Manca, A., et al. (2003) A Case of Adult-Onset Tubulointerstitial Nephritis and Uveitis (“TINU Syndrome”) Associated with Sacroiliitis and Epstein-Barr Virus Infection with Good Spontaneous Outcome. American Journal of Kidney Diseases, 42, E11.1-E11.7.
 Stupp, R., Mihatsch, M.J., Matter, L. and Streuli, R.A. (1990) Acute Tubulointerstitial Nephritis with Uveitis (TINU Syndrome) in a Patient with Serologic Evidence for Chlamydia Infection. Klinische Wochenschrift, 68, 971-975.
 Levinson, R.D., Park, M.S., Rikkers, S.M., Reed, E.F., Smith, J.R., Martin, T.M., et al. (2003) Strong Associations between Specific HLA-DQ and HLA-DR alleles and the Tubulointerstitial Nephritis and Uveitis Syndrome. Investigative Ophthalmology & Visual Science, 44, 653-657.
 Perasaari, J., Saarela, V., Nikkila, J., Ala‐Houhala, M., Arikoski, P., Kataja, J., et al. (2013) HLA Associations with Tubulointerstitial Nephritis with or without Uveitis in Finnish Pediatric Population: A Nation-Wide Study. Tissue Antigens, 81, 435-441.
 Vanhaesebrouck, P., Carton, D., De Bel, C, Praet, M. and Proesmans, W. (1985) Acute Tubulointerstitial Nephritis and Uveitis Syndrome (TINU Syndrome). Nephron, 40, 418-422.
 Lee, J.W., Kim, H.J., Sung, S.H. and Lee, S.J. (2005) A Case of Tubulointerstitial Nephritis and Uveitis Syndrome with Severe Immunologic Dysregulation. Pediatric Nephrology, 20, 1805-1808.
 Wakaki, H., Sakamoto, H. and Awazu, M. (2001) Tubulointerstitial Nephritis and Uveitis Syndrome with Autoantibody Directed to Renal Tubular Cells. Pediatrics, 107, 1443-1446.
 Abed, L., Merouani, A., Haddad, E., et al. (2008) Presence of Autoantibodies against Tubular and Uveal Cells in a Patient with Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome. Nephrology Dialysis Transplantation, 23, 1452-145.
 Tan, Y., Yu, F., Qu, Z., Su, T., Xing, G.Q., Wu, L.H., et al. (2011) Modified C-Reactive Protein Might Be a Target Autoantigen of TINU Syndrome.American Society of Nephrology, 6, 93-100.
 Onyekpe, I., Shenoy, M., Denley, H., Riad, H., Webb, N.J.A. (2011) Recurrent Tubulointerstitial Nephritis and Uveitis Syndrome in a Renal Transplant Recipient. Nephrology Dialysis Transplantation, 26, 3060-3062.
 Yao, Y.H., Lin, C.C., Chung, Y.M., Yang, A.-H., Li, S.-Y., Lin, C.-C., et al. (2011) Tubulointerstitial Nephritis and Uveitis Syndrome (TINU) with Fanconi’s Syndrome. Clinical Nephrology, 75, 75-78.
 Igarashi, T., Kamoshita, K.H., Kamoshita, S., Nosaka, K., Seiya, K. and Hayakawa, H. (1992) Acute Tubulointerstitial Nephritis with Uveitis Syndrome Presenting as Multiple Tubular Dysfunction Including Fanconi’s Syndrome. Pediatric Nephrology, 6, 547-549.
 Thajudeen, B., Bracamonte, E., Bracamonte, E., Sussman, A., Lien, Y.-H.H. (2014) Polyuric Kidneys and Uveitis: An Oculorenal Syndrome. American Journal of Case Reports, 15, 530-533.
 Kase, S., Kitaichi, N., Namba, K., Miyazaki, A., Yoshida, K., Ishikura, K., et al. (2006) Elevation of Serum Krebs von den Lunge-6 Levels in Patients with Tubulointerstitial Nephritis and Uveitis Syndrome. American Journal of Kidney Diseases, 48, 935-941.
 Thomassen, V.H., Ring, T., Thaarup, J. and Baggesen, K. (1998) Acute Tubulointerstitial Nephritis and Uveitis Syndrome (TINU Syndrome). Occurrence of Uveitis after Stopping Steroids. Nephrology Dialysis Transplantation, 13, 1892-1893.
 Sinnamon, K.T, Courtney, A.E., Harron, C. and O’ Rourke, M. (2008) Tubulointertiteil Nephritis and Uveitis 5TINU) Syndrome/ Epidemiology, Diagnosis and Management.NDT Plus, 1, 112-116.
 Pepple, K.L., Lam, D.L., Finn, L.S. and Van Gelder, R. (2015) Urinary β2 Microglobulin Testing in Pediatric Uveitis: A Case Report of a 9-Year-Old Boy with Renal and Ocular Sarcoidosis. Case Reports in Ophthalmology, 6, 101-105.
 Cavazza, S. and Molinari, P.P. (1994) Bilateral Intermediate Uveitis and Acute Interstitial Nephritis (TINU Syndrome). Ultrasonographic Documentation of a Case]. Journal Français D’Ophtalmologie, 17, 59-61.
 Waeben, M., Boven, K., D’Heer, B. and Tassignon, M.J. (1996) Tubulointerstitial Nephritis-Uveitis (TINU)-Syndrome with Posterior Uveitis. Bulletin de la Societe Belge d’Ophtalmologie, 261, 73-76.
 Ali, A. and Rosenbaum, J.T. (2014) TINU (Tubulointerstitial Nephritis Uveitis) Can Be Associated with Chorioretinal Scars. Ocular Immunology and Inflammation, 22, 213-217.
 Takemoto, Y., Namba, K., Mizuuchi, K., Ohno, S. and Ishida, S. (2013) Two Cases of Subfoveal Choroidal Neovascularization with Tubulointerstitial Nephritis and Uveitis Syndrome. European Journal of Ophthalmology, 23, 255-257.
 Sherman, M.D. and Own, K.H. (1999) Interstitial Nephritis and Uveitis Syndrome Presenting with Bilateral Optic Disc Edema. American Journal of Ophthalmology, 127, 609-610.
 Welzl-Hinterkorner, E. and Tholen, A. (2000) Bilateral Cystoid Macular Edema in an Older Female Patient with Tubulointerstitial Nephritis and Uveitis (TINU Syndrome). Klinische Monatsblätter für Augenheilkunde, 216, 116-117.
 Hudde, T., Heinz, C., Neudorf, U., Hoef, S., Heiligenhaus, A. and Steuhl, K.-Peter (2002) Tubulointerstitial Nephritis and Uveitis (TINU Syndrome)—Comorbidity and Complications in Four Patients. Klinische Monatsblätter für Augenheilkunde, 219, 528-532.
 Daniel, E., Gangaputra, S., Kempen, J.H. and Jabs, D.A. (2006) Recurrent Nodular scleritis Preceding an Adult TINU Syndrome. Ocular Immunology and Inflammation, 14, 239-240.
 Asproudis, I., Zafeiropoulos, P., Katsanos, A., Skamantzoura, E. and Sionti, I. (2013) Tubulointerstitial Nephritis and Uveitis Syndrome with Concomitant Hashimoto’s Thyroiditis. Journal of Pediatric Ophthalmology and Strabismus, 50, e1-e3.
 Yanagihara, T., Kitamura, H., Aki, K., Kuroda, N. and Fukunaga, Y. (2009) Serial Renal Biopsies in Three Girls with Tubulointerstitial Nephritis and Uveitis Syndrome. Pediatric Nephrology, 24, 1159-1164.
 Koike, K., Iida, S., Usui, M., Matsumoto, Y., Fukami, K., Ueda, S., Tamaki, K., Kato, S. and Okuda, S. (2007) Adult-Onset Acute Tubulointerstitial Nephritis and Uveitis with Fanconi Syndrome. Clinical Nephrology, 67, 255-259.
 Izzedine, H., Launay, B.B., Launay-Vacher V. and Deray, G. (2004) Vacher Oculorenal Disorders in Systemic Autoimmune Diseases. American Journal Kidney Disease, 43, 209-222.
 Izzedine, H., Buhaescu, I., Bodaghi, B., Martinez, V., Caumes, E., LeHoang, P. (2004) Oculo-Renal Disorders in Infectious Diseases. International Ophthalmology, 23, 299-319.
 Buscher, R., Vij, O., Hudde, T., Hoyer, P.F. and Vester, U. (2004) Pseudotumor Cerebri Following Cyclosporine A Treatment in a Boy with Tubulointerstitial Nephritis Associated with Uveitis. Pediatric Nephrology, 19, 558-560.
 Hausler, U., Guminski, B., Helmchen, U., Kisters, K., Heinz, C. and Braun, J. (2013) Tubulointerstitial Nephritis with Uveitis (TINU) Syndrome. A Relatively Rare Rheumatological Differential Diagnosis with Unexplained Uveitis. Zeitschrift für Rheumatologie, 72, 393-397.
 Jahnukainen, T., Ala-Houhala, M., Kataja, J., Kataja, J., Saarela, V. and Nuutinen, M. (2011) Clinical Outcome and Occurrence of Uveitis in Children with Idiopathic Tubulointerstitial Nephritis. Pediatric Nephrology, 26, 291-299.
 Taheri, S. and Taheri, D. (2009) Short Course of Cyclophosphamide Therapy May Reduce Recurrence in Patients with Tubulointerstitial Nephritis and Uveitis Syndrome. Saudi Journal of Kidney Disease and Transplantation, 20, 655-657.
 Filler, G., Hansen, M., Leblanc, C., Lepage, N., Franke, D., Mai, I., et al. (2003) Pharmacocinetics of Mycophenolate Mofetil for Autoimmune Isease in Children. Pediatric Nephrology, 18, 445-449.
 Vohra, S., Eddy, A., Levin, A.V., Taylor, G. and Laxer, R.M. (1999) Tubulointerstitial Nephritis and Uveitis in Children and Adolescents. Four New Cases and a Review of the Literature. Pediatric Nephrology, 13, 426-432.
 Gion, N., Stravrou, P. and Foster, C.S. (2000) Immunomodulatory Therapy for Chronic Tubulointertitiel Nephritis Associated Uveitis. American Journal of Ophthalmology, 129, 764-768.